Consistent with our results in CTCs, nPKC-θ expression was higher in CD8+ T cells isolated from patients with immunotherapy-resistant stage IV metastatic melanoma than those with immunotherapy-responsive disease (Figure 6A and Figure S5A). The gene discussed is CD8A; the disease is metastatic melanoma.